Emerging AI Advances in Cardiac Imaging
In a recent video interview, David Ouyang, M.D., shared insights from two recent studies he co-authored on the use of artificial intelligence (AI) to improve initial assessment of left ventricular ejection fraction (LVEF) on echocardiography and ascertain cardiac risks associated with changes in the left ventricle sphericity index seen on magnetic resonance imaging (MRI).
Study Shows Significant Incidental Findings in Nearly 34 Percent of Lung Screening CT Exams
In a large retrospective study of 26,455 participants from the National Lung Screening Trial, low dose computed tomography (LDCT) exams revealed significant incidental findings (SIFs), ranging from emphysema to suspicious lesions, in 8,954 participants.
Do the New USPSTF Recommendations Go Far Enough on Mammography Screening?
The United States Preventive Services Task Force (USPSTF) has drawn praise for lowering the age threshold for initial mammography screening from 50 to 40 years of age in updated draft recommendations for breast cancer screening, but critics warn that biennial screening is not sufficient for higher-risk populations.
Brain PET Study Suggests Link Between Early Amyloid Accumulation and Repetitive Subconcussive Trauma
After five months of exposure to repeated blast events, the majority of nine otherwise healthy military instructors had significantly increased amyloid deposition in the brain, according to positron emission tomography (PET) findings from a new study.
New Study Shows Viability of Adjunctive AI for Breast Ultrasound
Adjunctive use of an artificial intelligence (AI) software demonstrated nearly equivalent sensitivity and over 28 percent higher accuracy in comparison to radiologist assessment of breast ultrasound images for breast lesions, according to new research presented at the recent Society of Breast Imaging (SBI) conference.
Study Finds Non-Contrast CT 30 Percent Less Accurate than CECT for Abdominal Pain in the ER
In a study involving 201 consecutive patients presenting to emergency departments (EDs) with abdominal pain, researchers found that radiology faculty accuracy rates in interpreting non-contrast, abdominopelvic computed tomography (CT) scans ranged from 68 to 74 percent.
New ACR Guidelines Emphasize Earlier Mammography Screening for High-Risk Women
While calling for a universal breast cancer risk assessment by the age of 25, the American College of Radiology (ACR) emphasized that ascertaining screening needs prior to the age of 40 is particularly important in high-risk populations such as Black women, who are 42 percent more likely to die from breast cancer in comparison to non-Hispanic White women.
Can Alternative MRI Techniques Help Enhance CyberKnife Treatment Imaging?
May 4th 2023In a review of the literature, this author discusses the viability of artificial intelligence (AI), parallel imaging, compressed sensing and simultaneous multi-slice excitation for improving the scan times and use of magnetic resonance imaging (MRI) to facilitate CyberKnife treatment.
Study Shows Benefits of AI for Prostate Cancer Detection on Multiparametric MRI
The use of adjunctive artificial intelligence (AI) reportedly improved lesion level sensitivity by nearly 19 percent and patient level specificity by 14 percent for the diagnosis of clinically significant prostate cancer on multiparametric magnetic resonance imaging (MRI).
What a New Study Reveals About AI, Bias and Mammography Assessment
Regardless of experience level, radiologists are likely to be affected by automation bias when utilizing adjunctive artificial intelligence (AI) for mammography interpretation, according to newly published research.
In a recent video interview from the American Urological Association (AUA) 2023 Annual Meeting, Brian Helfand, M.D., discussed emerging research that shows the potential viability of the agent F18-rhPSMA-7.3 for enhancing the detection of prostate cancer recurrence and facilitating earlier intervention for patients with low prostate-specific antigen (PSA) levels.
FDA Clears RadNet's Updated AI Software for Prostate MRI
An update to Quantib Prostate 2.1, Quantib Prostate 3.0 reportedly facilitates workflow advances and offers a variety of tools, ranging from artificial intelligence (AI)-based segmentation to PI-RADS scoring support, to help improve interpretation of prostate magnetic resonance imaging (MRI).
CT Update: FDA Changes Course on Post-ICM Thyroid Monitoring in Young Children
Revising a March 2022 recommendation, the Food and Drug Administration (FDA) said thyroid monitoring for young children three years of age and under receiving iodinated contrast media (ICM) in relation to contrast-enhanced computed tomography (CECT) can now be reserved for those with risk factors including prematurity, low birth weight or conditions affecting thyroid function.